Elevated serum IgG1, complement activation, and clinical severity in IgG4-related disease: a comprehensive subgroup analysis
Clinical Rheumatology · 2026
DOI: 10.1007/s10067-026-08264-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Rheumatology, 2026. Verfasst von Xia Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Beijing Friendship Hospital, Capital Medical University, 95th, Yongan Road, Beijing, 100050, China. Hauptthemen laut MEDLINE: Immunoglobulin G, Immunoglobulin G4-Related Disease, Complement Activation. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
INTRODUCTION: OBJECTIVES: To evaluate the clinical associations of elevated serum IgG1 and to assess the utility of integrating IgG1 with IgG4 for patient stratification in IgG4-related disease (IgG4-RD). METHOD: This retrospective study included 344 treatment-naïve IgG4-RD patients. Patients were first classified into elevated and non-elevated IgG1 groups based on the institutional laboratory upper limit of normal (ULN) (cutoff: 10.11 g/L). Subsequently, to explore distinct immunopathological phenotypes, patients were further stratified into four groups by integrating this IgG1 cutoff with an IgG1/IgG4 ratio cutoff of 1.0. Subgroup analyses were performed based on gender and the presence of lung, kidney, or liver involvement. RESULTS: Patients with elevated IgG1 (> 10.11 g/L, n = 137) were older, more frequently male, and had higher disease activity, more organ involvement, and increased lung, kidney, and liver involvement (all P 10.11 g/L and IgG1/IgG4 10.11 g/L) defines a severe IgG4-RD phenotype with higher disease activity, multi-organ involvement, and profound complement consumption. • A novel serological signature, "Elevated IgG1, non-IgG1-dominant" (IgG1>10.11 g/L and IgG1/IgG 4
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Beijing Friendship Hospital, Capital Medical University, 95th, Yongan Road, Beijing, 100050, China.
- Department of Pharmacy, Beijing Friendship Hospital, Capital Medical University, 95th, Yongan Road, Beijing, 100050, China.
- Department of Rheumatology and Immunology, Beijing Shunyi Hospital, 3rd, Guangming South Road, Beijing, 101300, China.
- Department of Rheumatology and Immunology, Beijing Friendship Hospital, Capital Medical University, 95th, Yongan Road, Beijing, 100050, China. Liuyanying6850@126.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, X., Zhang, T., Pan, C., Hao, Q., Lian, D., Xu, Y., Yan, R., Zhou, H., Qi, H., & Liu, Y. (2026). Elevated serum IgG1, complement activation, and clinical severity in IgG4-related disease: a comprehensive subgroup analysis. Clinical Rheumatology. https://doi.org/10.1007/s10067-026-08264-y
Vancouver
Zhang X, Zhang T, Pan C, Hao Q, Lian D, Xu Y, et al. Elevated serum IgG1, complement activation, and clinical severity in IgG4-related disease: a comprehensive subgroup analysis. Clinical Rheumatology. 2026. doi:10.1007/s10067-026-08264-y
BibTeX
@article{Zhang2026,
author = {Zhang, Xia and Zhang, Tong and Pan, Chen and Hao, Qiyuan and Lian, Difei and Xu, Yuetong and Yan, Rui and Zhou, Hang and Qi, Haiyu and Liu, Yanying},
title = {Elevated serum IgG1, complement activation, and clinical severity in IgG4-related disease: a comprehensive subgroup analysis},
journal = {Clinical Rheumatology},
year = {2026},
doi = {10.1007/s10067-026-08264-y}
}
EUVIMED